omeprazole has been researched along with Pulmonary Arterial Remodeling in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Omeprazole treatment increased the aortic cross-sectional area and media/lumen ratio by 25% (P < 0." | 1.62 | Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation. ( Castro, MM; Conde, SO; Nogueira, RC; Oliveira-Paula, GH; Parente, JM; Pinheiro, LC; Sanches-Lopes, JM; Tanus-Santos, JE, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nogueira, RC | 1 |
| Pinheiro, LC | 1 |
| Sanches-Lopes, JM | 1 |
| Parente, JM | 1 |
| Oliveira-Paula, GH | 1 |
| Conde, SO | 1 |
| Castro, MM | 1 |
| Tanus-Santos, JE | 1 |
1 other study available for omeprazole and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation.
Topics: Allopurinol; Animals; Anti-Ulcer Agents; Aorta; Enzyme Inhibitors; Gene Expression Regulation, Enzym | 2021 |